World's Best Scientists 2026 revealed!
Henrik Klitgaard

Henrik Klitgaard

D-Index & Metrics

Neuroscience

D-Index
51
Citations
8896
World Ranking
5552
National Ranking
66

Henrik Klitgaard publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Henrik Klitgaard sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 105 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Henrik Klitgaard D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Henrik Klitgaard sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 51 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Henrik Klitgaard is affiliated with UCB Pharma in Belgium and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research predominantly focuses on epilepsy, pharmacological effects, and RNA-related therapeutic approaches within neurological and neurogenetic disorders.

Klitgaard's work spans several core research topics including:

  • Epilepsy research and treatment
  • Pharmacological effects and toxicity studies
  • Schizophrenia research and treatment
  • RNA interference and gene delivery
  • Drug transport and resistance mechanisms
  • RNA regulation and disease
  • Neurogenetic and muscular disorders research

Their recent publications reveal an emphasis on epilepsy and neuropharmacology, with papers such as:

  • "Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?", 2020, Epilepsia
  • "Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review", 2021, Epilepsy & Behavior
  • "Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases", 2022, RNA Biology
  • "Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications", 2024, Frontiers in Pharmacology
  • "Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A", 2022, EJNMMI Research

The prominent publication venues for Klitgaard include:

  • Epilepsia
  • Epilepsy & Behavior
  • RNA Biology
  • Frontiers in Pharmacology
  • EJNMMI Research

Frequent co-authors working alongside Klitgaard are:

  • Stine N. Hansen
  • Pavel Klein
  • Sakari Kauppinen
  • Bernhard J. Steinhoff
  • Cédric Laloyaux

Klitgaard's subfields of study emphasize psychiatry and mental health, molecular biology, genetics, physiology, as well as pediatrics, perinatology, and child health, reflecting a multidisciplinary approach to neurological and genetic disorders.

Best Publications

  • New avenues for anti-epileptic drug discovery and development

    Wolfgang Löscher;Henrik Klitgaard;Roy E. Twyman;Dieter Schmidt

  • Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.

    Henrik Klitgaard;Alain Matagne;Jean Gobert;Ernst Wülfert

  • The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

    Jean-Michel Rigo;Grégory Hans;Laurent Nguyen;Véronique Rocher

  • Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.

    Benoit M Kenda;Alain C Matagne;Patrice E Talaga;Patrick M Pasau

  • Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slices

    Isabelle Niespodziany;Henrik Klitgaard;Doru Georg Margineanu

  • Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

    Pavel Klein;Raymond Dingledine;Eleonora Aronica;Christophe Bernard

  • Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A

    Alain Matagne;D-G Margineanu;Benoît Kenda;Philippe Michel

  • SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy.

    Rafal M. Kaminski;Alain Matagne;Karine Leclercq;Michel Gillard

  • Levetiracetam does not modulate neuronal voltage-gated Na+and T-type Ca2+currents

    Cristina Zona;Isabelle Niespodziany;Caterina Marchetti;Henrik Klitgaard

  • Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?

    Henrik Klitgaard

  • Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?

    Michael Madeja;Doru Georg Margineanu;Ali Gorji;Elke Siep

  • Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment

    Henrik Klitgaard;Alain Matagne;Jean-Marie Nicolas;Michel Gillard

  • Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man

    Alain Matagne;Henrik Klitgaard

  • Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond

    Wolfgang Löscher;Michel Gillard;Zara A. Sands;Rafal M. Kaminski

  • Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs

    Doru Georg Margineanu;Henrik Klitgaard

  • Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.

    Jean‐Marie Nicolas;Jonas Hannestad;Daniel Holden;Sophie Kervyn

  • Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia

    Etienne Hanon;Henrik Klitgaard

  • Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.

    Rafal M. Kaminski;Michel Gillard;Karine Leclercq;Etienne Hanon

  • Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracelullar striatal dopamine

    Wassilios Meissner;Paula Ravenscroft;René Reese;René Reese;Daniel Harnack

  • Pilocarpine-induced epileptogenesis in the rat:: Impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations

    Henrik Klitgaard;Alain Matagne;Jocelyne Vanneste-Goemaere;Doru-Georg Margineanu

  • Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.

    Andrey M Mazarati;Roger Baldwin;Henrik Klitgaard;Alain Matagne

Frequent Co-Authors

Erwan Bezard
Erwan Bezard University of Bordeaux
Yiyun Huang
Yiyun Huang Yale University
Richard E. Carson
Richard E. Carson Yale University
Jonathan M. Brotchie
Jonathan M. Brotchie University Health Network
Nabeel Nabulsi
Nabeel Nabulsi Yale University
Claude G. Wasterlain
Claude G. Wasterlain University of California, Los Angeles
Dieter Schmidt
Dieter Schmidt Freie Universität Berlin
Amy R. Brooks-Kayal
Amy R. Brooks-Kayal University of Colorado Denver
Alan R. Crossman
Alan R. Crossman University of Manchester
Asla Pitkänen
Asla Pitkänen University of Eastern Finland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Henrik Klitgaard

Trending Scientists

Recently Published Articles